Regeneron Pharmaceuticals Inc
(LTS:0R2M)
$
676.38
+3.995 (+0.59%)
Market Cap: 70.47 Bil
Enterprise Value: 64.42 Bil
PE Ratio: 16.38
PB Ratio: 2.25
GF Score: 87/100 Regeneron Pharmaceuticals Inc at Jefferies London Healthcare Conference Transcript
Nov 15, 2023 / 02:30PM GMT
Release Date Price:
$797.66
(+0.24%)
Akash Tewari
Jefferies LLC, Research Division - Equity Analyst
Good afternoon, everyone. I was just joking with the Regeneron team that [if] there's a biotech bear market, I don't see it in London. These are packed rooms. It's really great to see everyone. And this is -- I also think that we're going to have an XBI rally. But that's my hot take for the day. That aside, I do have the pleasure of hosting the Regeneron team, Bob Landry, CFO; and then Ryan Crowe, Head of Investor Relations.
I will hand it off to them to make some introductory remarks and then we'll get started.
Ryan Crowe
Regeneron Pharmaceuticals, Inc. - VP of IR
Thanks, Akash. Great to be here again. And this is a very crowded conference. I think it might be time for a bigger hotel.
Akash Tewari
Jefferies LLC, Research Division - Equity Analyst
The claustrophobia is a feature, not a [function].
Ryan Crowe
Regeneron Pharmaceuticals, Inc. - VP of IR
I see. Anyway, I'll do some FLS disclaimer
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot